Digital Diabetes Management Market to Reach $17.11 Bn, Globally, by 2026

 Allied Market Research published a report, titled, "Digital Diabetes Management Market by type (Handheld Devices and Wearable Devices), Product (Continuous blood glucose monitoring systems, Smart Glucose Meter, Smart Insulin Pumps, Smart Insulin Pens and Apps): Global Opportunity Analysis and Industry Forecast, 2019-2026." As per the report, the global Digital Diabetes Management Market was estimated at $3.37 billion in 2018 and is expected to hit $17.11 billion by 2026, registering a CAGR of 22.5% from 2019 to 2026.

Drivers, restraints, and opportunities-

Increase in adoption of smartphones & tablets integrated with healthcare apps and rise in diabetic population globally drive the growth of the global digital diabetes management market. On the other hand, lack of awareness regarding digital diabetes management in developing countries and data privacy concerns among patients restrain the growth to some extent. However, high potential for development offered by emerging markets is expected to create multiple opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6417

The continuous blood glucose monitoring systems segment to lead the trail by 2026-

Based on product, the continuous blood glucose monitoring systems segment contributed to more than two-fifths of the global digital diabetes management market share in 2018, and is expected to rule the roost throughout the forecast period. This is attributed to increase in geriatric population and high prevalence of population suffering from diabetic symptoms. The smart insulin pumps segment, on the other hand, would cite the fastest CAGR of 24.3% by the end of 2026. Surge in demand for home infusion therapy and increase in number of patients suffering from diabetes fuel the segment growth.

The wearable devices segment to dominate during the estimated period-

Based on type, the wearable devices segment accounted for more than half of the global digital diabetes management market revenue in 2018, and is projected to lead the trail from 2019 to 2026. The same segment would grow at the fastest CAGR of 23.9% through 2026. This is due to the various benefits it provides, such as behavioral interventions to people, better accessibility, scalability, and the ability to test anywhere, which works best for remote users.

North America to maintain its top status during the study period-

Based on region, North America garnered the major share, generating two-fifths of the global digital diabetes management market. Simultaneously, the Asia-Pacific region is anticipated to portray the fastest CAGR of 24.7% by 2026. Increasing awareness regarding digital health and large number of patients suffering from chronic illness are projected to dole out lucrative opportunities for digital diabetes management device manufacturers in this region. Rise in the incidences of chronic diseases such as diabetes, obesity, and heart disorder, and increase in demand for home-based therapies and consultation drive the growth of the market.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6417 

Frontrunners in the industry-

  • ACON Laboratories, Inc.
  • Terumo corporation
  • Abbott laboratories
  • Becton
  • Dickinson and Company
  • Bayer AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Johnson and Johnson
  • Medtronic Plc.
  • Novo Nordisk A/S

Comments

Post a Comment

Popular posts from this blog

$1,082.44+ Million Breast Biopsy Market key highlights driving the industry CAGR of 5.1% Forecast, 2024-2030

Image
  The global  breast biopsy market , valued at $658.17 million in 2020, is projected to reach $1,082.44 million by 2030, growing at a compound annual growth rate (CAGR) of 5.1%. As breast biopsies play a crucial role in diagnosing breast cancer, advancements in technology, and rising awareness, the market is experiencing steady growth. Below are some of the key highlights driving the industry: 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:  https://www.alliedmarketresearch.com/request-sample/1067 1. Breast Biopsy: A Diagnostic Tool Breast biopsies are essential for diagnosing breast cancer and identifying other conditions through physical examinations. The most common method is fine needle aspiration biopsy (FNAB), a minimally invasive procedure that leaves no scarring. Additionally, ultrasound-guided biopsies use real-time imaging to locate tissue, while stereotactic mammography uses images from various angles to precisely guide the needle. 2. High Efficacy ...
Read more

The Future of Cell Culture Media Market Growth, Trends, and Opportunities (2025-2035)

  The global  cell culture media market , valued at $5.2 billion in 2023, is projected to surge to $17.6 billion by 2035, growing at a CAGR of 10.7% from 2024 to 2035. This exponential growth is fueled by rising demand for biopharmaceuticals, vaccines, and gene therapies, driven by increasing cases of cancer, autoimmune disorders, and infectious diseases. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/A47229
Read more

The Surging Demand for Surgical Masks in India: Trends, Challenges, and Opportunities

  https:// www.alliedmarketresearch.com/surgical-mask-market Surgical masks have become an essential component of healthcare and personal hygiene, playing a crucial role in infection control. In India, the surgical mask market has seen exponential growth, fueled by increased healthcare awareness, rising surgical procedures, and pandemic-induced demand. The market, valued at $71.73 million in 2019, is projected to reach $157.13 million by 2027, growing at a CAGR of 10.3%. Get a Sample Copy of this Report:  https://www.alliedmarketresearch.com/request-sample/5125 Key Growth Drivers 1. Rising Surgical Procedures • India has a high prevalence of infectious diseases, neonatal disorders, and non-communicable diseases, leading to an increased number of surgical interventions. • The growing number of surgeries has directly boosted demand for surgical masks and other disposable protective gear. 2. Increasing Awareness of Hospital-Acquired Infections (HAIs) • HAIs pose a significant thr...
Read more